Quantification of CT-assessed radiation-induced lung damage in lung cancer patients treated with or without chemotherapy and cetuximab

References

• Vansteenkiste J, De Ruysscher D, Eberhardt WEE, Lim E, Senan S, Felip E, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 October 1, 2013;24(suppl 6):vi89–vi98.
   Google Scholar
• Jenkins P, Welsh A. Computed tomography appearance of early radiation injury to the lung: Correlation with clinical and dosimetric factors. Int J Radiat Oncol Biol Phys 2011;81:97–103.
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang J, Zhou S, Hubbs JL, Foltz RJ, Hollis DR, et al. Regional lung density changes after radiation therapy for tumors in and around thorax. Int J Radiat Oncol Biol Phys 2010;76:116–22.
   PubMed Web of Science ®Google Scholar
• Kimura T, Matsuura K, Murakami Y, Hashimoto Y, Kenjo M, Kaneyasu Y, et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006;66:483–91.
   PubMed Web of Science ®Google Scholar
• Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 2009;91:421–6.
   PubMed Web of Science ®Google Scholar
• Yirmibesoglu E, Higginson DS, Fayda M, Rivera MP, Halle J, Rosenman J, et al. Challenges scoring radiation pneumonitis in patients irradiated for lung cancer. Lung Cancer 2012;76:350–3.
   PubMed Web of Science ®Google Scholar
• Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S70–6.
   PubMed Web of Science ®Google Scholar
• Robbins ME, Brunso-Bechtold JK, Peiffer AM, Tsien CI, Bailey JE, Marks LB. Imaging radiation-induced normal tissue injury. Radiat Res 2012;177:449–66.
   PubMed Web of Science ®Google Scholar
• Andreassen CN, Barnett GC, Langendijk JA, Alsner J, De Ruysscher D, Krause M, et al. Conducting radiogenomic research – do not forget careful consideration of the clinical data. Radiother Oncol 2012;105:337–40.
   PubMed Web of Science ®Google Scholar
• Palma DA, van Sornsen de Koste JR, Verbakel WF, Senan S. A new approach to quantifying lung damage after stereotactic body radiation therapy. Acta Oncol 2011;50:509–17.
   PubMed Web of Science ®Google Scholar
• Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Int J Radiat Oncol Biol Phys 2012;84:1024–30.
   PubMed Web of Science ®Google Scholar
• Mah K, Van Dyk J, Keane T, Poon PY. Acute radiation-induced pulmonary damage: A clinical study on the response to fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1987;13:179–88.
   PubMed Web of Science ®Google Scholar
• Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181–90.
   PubMed Web of Science ®Google Scholar
• Govindan R, Bogart J, Stinchcombe T, Wang X, Hodgson L, Kratzke R, et al. Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407. J Clin Oncol 2011;29:3120–5.
   PubMed Web of Science ®Google Scholar
• Blumenschein GR, Jr.Paulus R, Curran WJ, Robert F, Fossella F, Werner-Wasik M, et al. Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324. J Clin Oncol 2011;29:2312–18.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Belderbos J, Reymen B, van Elmpt W, van Baardwijk A, Wanders R, et al. State of the art radiation therapy for lung cancer 2012: A glimpse of the future. Clin Lung Cancer 2013;14:89–95.
   PubMed Web of Science ®Google Scholar
• Dingemans AM, Bootsma G, van Baardwijk A, Reymen B, Wanders R, Brans B, et al. A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer. J Thorac Oncol 2014;9:710–16.
   PubMed Web of Science ®Google Scholar
• van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans AM, et al. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. J Clin Oncol 2010;28:1380–6.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, van Baardwijk A, Steevens J, Botterweck A, Bosmans G, Reymen B, et al. Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study. Radiother Oncol 2012;102:228–33.
   PubMed Web of Science ®Google Scholar
• Reymen B, Van Loon J, van Baardwijk A, Wanders R, Borger J, Dingemans AM, et al. Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer. Int J Radiat Oncol Biol Phys 2013;85:1319–24.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans CW, Le Pechoux C, Price A, et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 2010;28:5301–10.
   PubMed Web of Science ®Google Scholar
• Bosmans G, Buijsen J, Dekker A, Velders M, Boersma L, De Ruysscher D, et al. An “in silico” clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients. Radiother Oncol 2006;81:73–80.
   PubMed Web of Science ®Google Scholar
• Janssens G, Jacques L, Orban de Xivry J, Geets X, Macq B. Diffeomorphic registration of images with variable contrast enhancement. Int J Biomed Imaging 2011;2011:891585.
   PubMedGoogle Scholar
• Spijkerman J, Fontanarosa D, Das M, van Elmpt W. Validation of nonrigid registration in pretreatment and follow-up PET/CT scans for quantification of tumor residue in lung cancer patients. J Appl Clin Med Phys 2014;15:4847.
   PubMedGoogle Scholar
• Boersma LJ, Damen EM, de Boer RW, Muller SH, Roos CM, Valdes Olmos RA, et al. Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. Radiother Oncol 1994;32:201–9.
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Method Ecol Evol 2013;4:133–42.
   Web of Science ®Google Scholar
• Ma J, Zhang J, Zhou S, Hubbs JL, Foltz RJ, Hollis DR, et al. Association between RT-induced changes in lung tissue density and global lung function. Int J Radiat Oncol Biol Phys 2009;74:781–9.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Sharifi H, Defraene G, Kerns SL, Christiaens M, De Ruyck K, et al. Quantification of radiation-induced lung damage with CT scans: The possible benefit for radiogenomics. Acta Oncol 2013;52:1405–10.
   PubMed Web of Science ®Google Scholar
• Phernambucq EC, Palma DA, Vincent A, Smit EF, Senan S. Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer. Lung Cancer 2011;74:451–6.
   PubMed Web of Science ®Google Scholar
• Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 1990;19:1569–74.
   PubMed Web of Science ®Google Scholar
• Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA. Radiosensitivity measurement of keratinocytes and fibroblasts from radiotherapy patients. Int J Radiat Oncol Biol Phys 1992;24:287–93.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 1994;4:68–80.
   PubMedGoogle Scholar
• van den Heuvel MM, Uyterlinde W, Vincent AD, de Jong J, Aerts J, Koppe F, et al. Additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Efficacy and safety outcomes of a randomized, multi-center phase II study investigating. Radiother Oncol 2014;110:126–31
   PubMed Web of Science ®Google Scholar
• Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys 2014;41:033502.
   PubMed Web of Science ®Google Scholar
• Cunliffe A, Armato III SG, Castillo R, Pham N, Guerrero T, Al-Hallaq HA. Lung texture in serial thoracic computed tomography scans: Correlation of radiomics-based features with radiation therapy dose and radiation pneumonitis development. Int J Radiat Oncol Biol Phys 2015;91:1048–56.
   PubMed Web of Science ®Google Scholar